Loading...
XMAD
RJF
, Last price  
Name

Laboratorio Reig Jofre SA

Chart & performance

D1W1MN
XMAD:RJF chart
P/E
—
P/S
—
EPS
0.06
Vol. 1Y
—
Shs. 5Y
1.28%
Rev. 5Y
7.55%
Div Yld LY
—
Div Yld TTM
—
Revenues
331m
-2.30%
90,762,000152,916,000161,019,000134,616,00038,841,00029,485,00029,926,00031,370,00033,284,362156,909,656161,134,290167,983,166180,467,786200,207,000230,079,000236,231,000271,150,000316,088,000338,895,000331,097,000
Net income
5m
-51.64%
4,549,0003,841,0001,491,000-44,907,000-22,618,00016,066,000-6,000953,0002,308,3948,749,7017,676,2888,828,4359,266,2774,942,0005,672,0005,092,0008,107,0009,407,00010,382,0005,021,000
CFO
2m
-95.17%
6,837,00031,568,00017,889,000-23,460,000-5,024,000-7,110,000-5,892,000396,000-3,305,53712,871,578-1,489,76320,693,07214,765,91411,679,00022,504,00014,497,00016,147,00019,115,00031,339,0001,514,000
Dividend
May 21, 20260.01944 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.

Related entities

Parent
REIG JOFRE INVESTMENTS S.L.

Key people

Isabel Reig Lopez
Chairman of the Board, Representative of Reig Jofre Investments SL · since 2015
Roser Gomila Zabala
Chief Financial Officer · since 2017
Gabriel Roig Zapatero
Chief Operating Officer · since 2017
Ignasi Biosca Reig
Chief Executive Officer, Executive Director · since 2015
Antonio Ballesteros Gomez
General Director of RJF Pharma Spain · since 2016
Alain Boutboul
General Director of Forte Pharma · since 2017
Ignacio Vila Rocafort
General Industrial Director
Adolf Rousaud Vinas
Non-Member Secretary of the Board · since 2015
Alejandro Garcia Reig
Vice Chairman of the Board · since 2017
Anton Costas Comesana
Independent Director · since 2015
Maria Luisa Francoli Plaza
Independent Director · since 2015
Ramon Gomis I de Barbara
Independent Director · since 2015
Ramiro Martinez-Pardo del Valle
Independent Director · since 2015
Independent Director · since 2015
IPO date
Nov 07, 2006
Employees
1,200
Domiciled in
ES
Incorporated in
ES
Headquarters & legal address
Gran Capità 10
Sant Joan Despí 08970
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT